ICP
Interchange Capital Partners Portfolio holdings
AUM
$433M
1-Year Est. Return
16.43%
1 Year Est. Return
+16.43%
AUM
$433M
AUM Growth
+$76.1M
(+21%)
Holding
291
Top Buys
| 1 | +$23M | |
| 2 | +$16.8M | |
| 3 | +$1.91M | |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.19M |
| 5 |
THRO
iShares U.S. Thematic Rotation Active ETF
THRO
|
+$1.13M |
Top Sells
| 1 | +$2.58M | |
| 2 | +$1.23M | |
| 3 | +$531K | |
| 4 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$467K |
| 5 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$399K |
Sector Composition
| 1 | Healthcare | 16.36% |
| 2 | Technology | 15.13% |
| 3 | Financials | 6.15% |
| 4 | Consumer Discretionary | 4.48% |
| 5 | Communication Services | 4.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
10x Genomics
TXG
$1.54B
| $122K | 0.03% |
10,503
-1,013
|
|
||
277
Recursion Pharmaceuticals
RXRX
$2.78B
| $101K | 0.02% |
19,930
-5,787
|
|
||
278
Intellia Therapeutics
NTLA
$2.67B
| $100K | 0.02% |
10,665
-1,202
|
|
||
279
Grab
GRAB
$23.3B
| $70K | 0.02% |
+13,922
|
|
||
280
Pacific Biosciences
PACB
$529M
| $22.7K | 0.01% |
18,307
-5,256
|
|
||
281
Booking.com
BKNG
$161B
| – | – |
-83
|
|
||
282
British American Tobacco
BTI
$111B
| – | – |
-6,034
|
|
||
283
Deckers Outdoor
DECK
$14.7B
| – | – |
-1,868
|
|
||
284
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.86B
| – | – |
-3,125
|
|
||
285
Gilead Sciences
GILD
$146B
| – | – |
-1,888
|
|
||
|
286
iShares Currency Hedged MSCI EAFE ETF
HEFA
$6.62B
| – | – |
-12,866
|
|
||
287
Lowe's Companies
LOW
$136B
| – | – |
-881
|
|
||
288
Lloyds Banking Group
LYG
$66.5B
| – | – |
-10,029
|
|
||
289
Schwab International Equity ETF
SCHF
$52.3B
| – | – |
-15,784
|
|
||
290
Sanofi
SNY
$122B
| – | – |
-5,439
|
|
||
|
291
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$12.7B
| – | – |
-9,796
|
|